Lai Quintin J 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Mar 16, 2022
Insider Transaction Report
Form 4
Lai Quintin J
VP Corp Development & Strategy
Transactions
- Exercise/Conversion
Common Stock
2022-03-14$94.27/sh+2,440$230,019→ 7,811.842 total - Sale
Common Stock
2022-03-14$371.89/sh−600$223,132→ 9,411.842 total - Sale
Common Stock
2022-03-14$374.45/sh−2,940$1,100,881→ 5,571.842 total - Sale
Common Stock
2022-03-14$370.94/sh−446$165,441→ 10,011.842 total - Sale
Common Stock
2022-03-14$374.92/sh−200$74,984→ 5,371.842 total - Exercise/Conversion
Common Stock
2022-03-14$83.47/sh+5,576$465,429→ 13,387.842 total - Sale
Common Stock
2022-03-14$369.86/sh−1,254$463,801→ 10,457.842 total - Sale
Common Stock
2022-03-14$372.92/sh−900$335,632→ 8,511.842 total - Exercise/Conversion
Stock Options (Right to buy)
2022-03-14−5,576→ 29,064 totalExercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (5,576 underlying) - Sale
Common Stock
2022-03-14$367.12/sh−1,271$466,604→ 12,116.842 total - Sale
Common Stock
2022-03-14$367.94/sh−405$149,017→ 11,711.842 total - Exercise/Conversion
Stock Options (Right to buy)
2022-03-14−2,440→ 34,640 totalExercise: $94.27From: 2018-02-05Exp: 2027-02-05→ Common Stock (2,440 underlying)
Footnotes (7)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F4]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F5]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F6]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F7]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.